Key result
Mildly elevated UACR conferred a 37% higher risk of composite cardiorenal outcomes compared to normal baseline levels.
Why the study?
Does mildly elevated urinary albumin-to-creatinine ratio (≥10 to <30 mg/g) increase cardiorenal risk in a cardiometabolic cohort?
Does mildly elevated urinary albumin-to-creatinine ratio (≥10 to <30 mg/g) increase cardiorenal risk in a cardiometabolic cohort?
Answers are grounded in this paper and cite their sources.
Cardiorenal risk rises continuously well before UACR reaches the traditional 30 mg/g threshold, emphasizing that the 'normal range' represents an actionable window for earlier prevention.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Yu et al. (2026) conducted an editorial in Cardiometabolic risk (n=93,634). Mildly elevated urinary albumin-to-creatinine ratio (UACR ≥10 to <30 mg/g) vs. UACR <10 mg/g was evaluated on Composite cardiorenal outcomes (HR 1.37, 95% CI 1.28-1.47). Mildly elevated UACR conferred a 37% higher risk of composite cardiorenal outcomes compared to normal baseline levels.
Synapse has enriched 10 related papers. Consider them for comparative context: